Fabrício Oliveira Souto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fabrício Oliveira Souto has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Matheus Santos de Sousa Fernandes
Keizo Asami Institute, Federal University of Pernambuco, Recife, Pernambuco, Brazil
11 shared publications - Angela Castoldi
Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany
7 shared publications - Fatma Hilal Yagin
Department of Biostatistics and Medical Informatics, Faculty of Medicine, Balikesir University, Balikesir 10145, Türkiye
5 shared publications - Gabriela Carvalho Jurema Santos
Federal University of Pernambuco Graduate Program in Nutrition, Physical Activity, and Phenotypic Plasticity Vitória de Santo Antão and Faculty of Nutrition, Federal University of Alagoas, Maceió, Brazil
5 shared publications Matheus Santos de Sousa Fernandes
Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
5 shared publicationsAngela Castoldi
Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife, Brazil
4 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1889960
Short-term environmental enrichment modulates brain region-specific redox responses in adolescent female mice
Background: Environmental enrichment (EE) is a non-pharmacological intervention known to enhance neuroplasticity and resilience. However, studies of EE on brain redox balance have focused predominantly on males and single regions, leaving the developing female brain and region-specific responses largely uncharacterized. This study investigated the effects of a three-week EE protocol on oxidative balance in the hippocampus, hypothalamus, and brainstem of adolescent female C57BL/6 mice. Methods: Lipid peroxidation was measured by thiobarbituric acid reactive substances (TBARS), and protein oxidation by carbonyl content. The enzymatic antioxidant system was evaluated through the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione S-transferase (GST). Non-enzymatic antioxidant defenses included quantification of reduced glutathione (GSH), oxidized glutathione (GSSG), the GSH/GSSG ratio, and total sulfhydryl content, providing an integrated assessment of redox homeostasis. Results: In the hippocampus, EE promoted a dual redox profile characterized by increased TBARS alongside reduced protein carbonylation, increased SOD activity, decreased GSSG, and elevated total sulfhydryl content. In the hypothalamus, EE exerted a protective effect, reducing both lipid and protein oxidation without altering enzymatic antioxidant activities. Instead, non-enzymatic defenses were selectively enhanced, as evidenced by increased GSH and sulfhydryl levels. In the brainstem, EE reduced oxidative damage markers and selectively increased SOD activity, while other antioxidant systems remained unchanged. Conclusion: Collectively, all regions exhibited reduced protein oxidative damage in our female-inclusive study design, but through different patterns: a dissociated hippocampal profile (increased TBARS with reduced protein oxidation and higher SOD/sulfhydryls), non-enzymatic thiol-based buffering in the hypothalamus, and SOD-centered defense in the brainstem, supporting a context-dependent model of oxidative regulation.
- 31 August 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1889960
Open AccessShort-term environmental enrichment modulates brain region-specific redox responses in adolescent female mice
Background: Environmental enrichment (EE) is a non-pharmacological intervention known to enhance neuroplasticity and resilience. However, studies of EE on brain redox balance have focused predominantly on males and single regions, leaving the developing female brain and region-specific responses largely uncharacterized. This study investigated the effects of a three-week EE protocol on oxidative balance in the hippocampus, hypothalamus, and brainstem of adolescent female C57BL/6 mice. Methods: Lipid peroxidation was measured by thiobarbituric acid reactive substances (TBARS), and protein oxidation by carbonyl content. The enzymatic antioxidant system was evaluated through the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione S-transferase (GST). Non-enzymatic antioxidant defenses included quantification of reduced glutathione (GSH), oxidized glutathione (GSSG), the GSH/GSSG ratio, and total sulfhydryl content, providing an integrated assessment of redox homeostasis. Results: In the hippocampus, EE promoted a dual redox profile characterized by increased TBARS alongside reduced protein carbonylation, increased SOD activity, decreased GSSG, and elevated total sulfhydryl content. In the hypothalamus, EE exerted a protective effect, reducing both lipid and protein oxidation without altering enzymatic antioxidant activities. Instead, non-enzymatic defenses were selectively enhanced, as evidenced by increased GSH and sulfhydryl levels. In the brainstem, EE reduced oxidative damage markers and selectively increased SOD activity, while other antioxidant systems remained unchanged. Conclusion: Collectively, all regions exhibited reduced protein oxidative damage in our female-inclusive study design, but through different patterns: a dissociated hippocampal profile (increased TBARS with reduced protein oxidation and higher SOD/sulfhydryls), non-enzymatic thiol-based buffering in the hypothalamus, and SOD-centered defense in the brainstem, supporting a context-dependent model of oxidative regulation.
- 17 March 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 185, 106645
Effects of environmental enrichment on the hippocampal microglial profile under neuroinflammatory conditions: A systematic review
- 17 March 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 185, 106645
Effects of environmental enrichment on the hippocampal microglial profile under neuroinflammatory conditions: A systematic review
- Open Access
- 22 January 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (2) , e70478
Can Environmental Enrichment Mitigate Cell Apoptosis in the Central Nervous System Under Adverse Health Conditions? A Systematic Review
To summarize the available evidence in the literature regarding the effects of exposure to an enriched environment (EE) on the modulation of apoptotic markers in central tissue of rodents under unfavorable conditions. Searches were conducted in three databases: PubMed/Medline (70 articles), Scopus (65 articles), and EMBASE (128 articles), all of which were subjected to eligibility criteria. Of the 263 articles found, 95 duplicates were removed. After evaluating the title and abstract, 147 studies were excluded, leaving 21 articles, 16 of which were included in this systematic review. EE was implemented using various inanimate objects. The disruptive event/condition included social isolation, cerebral ischemia, stroke, postpartum depression, accelerated aging, ischemia/reperfusion, high altitude, Alzheimer's disease, hypobaric hypoxia, infrasound exposure, sepsis, and exposure to sevoflurane. Regarding the expression of apoptotic markers, after EE exposure, there was a reduction in the expression of p‐IKKβ/IKKβ and p‐P65/P65 in the hippocampus, a reduction in Bax, as well as cleaved Caspase‐3, Cytochrome C, a reduction in the Bax/Bcl‐2 ratio, and p53. As for anti‐apoptotic markers, increased expression of Bcl‐2 was observed following EE exposure. This systematic review concludes that the benefits of EE can reduce apoptosis through the modulation of both pro‐apoptotic and anti‐apoptotic genes. In this regard, EE has been shown to be an important neuroprotective tool in various adverse conditions, mitigating cognitive deficits by reducing apoptosis related to cellular stress.
- 22 January 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (2) , e70478
Open AccessCan Environmental Enrichment Mitigate Cell Apoptosis in the Central Nervous System Under Adverse Health Conditions? A Systematic Review
To summarize the available evidence in the literature regarding the effects of exposure to an enriched environment (EE) on the modulation of apoptotic markers in central tissue of rodents under unfavorable conditions. Searches were conducted in three databases: PubMed/Medline (70 articles), Scopus (65 articles), and EMBASE (128 articles), all of which were subjected to eligibility criteria. Of the 263 articles found, 95 duplicates were removed. After evaluating the title and abstract, 147 studies were excluded, leaving 21 articles, 16 of which were included in this systematic review. EE was implemented using various inanimate objects. The disruptive event/condition included social isolation, cerebral ischemia, stroke, postpartum depression, accelerated aging, ischemia/reperfusion, high altitude, Alzheimer's disease, hypobaric hypoxia, infrasound exposure, sepsis, and exposure to sevoflurane. Regarding the expression of apoptotic markers, after EE exposure, there was a reduction in the expression of p‐IKKβ/IKKβ and p‐P65/P65 in the hippocampus, a reduction in Bax, as well as cleaved Caspase‐3, Cytochrome C, a reduction in the Bax/Bcl‐2 ratio, and p53. As for anti‐apoptotic markers, increased expression of Bcl‐2 was observed following EE exposure. This systematic review concludes that the benefits of EE can reduce apoptosis through the modulation of both pro‐apoptotic and anti‐apoptotic genes. In this regard, EE has been shown to be an important neuroprotective tool in various adverse conditions, mitigating cognitive deficits by reducing apoptosis related to cellular stress.
- Open Access
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 43
NLRP3 Inflammasome as Potential Predictor of Non-Responsiveness to Immunosuppressive Treatment in Lupus Nephritis
Lupus nephritis (LN) can affect up to 60% of patients with systemic lupus erythematosus (SLE). The NLRP3 inflammasome has been implicated in the pathogenesis of LN. This study aimed to evaluate the role of the NLRP3 inflammasome as a predictor of response to immunosuppressive treatment in patients with active LN. A prospective cohort study was conducted with 20 adult patients with active LN, classes III, IV, and V, from January 2021 to September 2023. Patients were followed up at biopsy (T0) and 6 months (T6) and 12 months (T12) after treatment and classified according to the primary efficacy renal response (PERR) at 12 months. Gene expression of NLRP3, CARD8, CASP1, IL1B, and IL18 was evaluated by RT-qPCR in PBMCs. Immunohistochemistry (IHC) for NLRP3 was performed on kidney tissue. The concentration of cytokine IL-1β was measured using the BD™ Cytometric Bead Array (CBA). The mean age was 31.9 ± 8.3 years, with 19 females and 1 male. After 12 months, 65% of patients achieved PERR. The IHC intensity in inflammatory cells was higher in patients with no PERR (p = 0.0426). In the no-PERR group, the gene expression of IL1B showed a significant increase at T6 (FC = 2.22: p = 0.0037) and T12 (FC = 2.91; p = 0.0001) compared with T0. Relative expression of IL1B was higher in no-PERR patients at T12 compared to the PERR group (p = 0.0477). The no-PERR group also had higher serum IL-1β levels compared to the PERR group at 12 months (2.9 ± 0.5 vs. 2.5 ± 0.7, p = 0.0164). In conclusion, our study evidenced an increase in IL1B expression and IL-1β levels over the 12 months of treatment in no-PERR patients, suggesting a potential biomarker of disease activity. Furthermore, a strong NLRP3 IHC staining score was associated with a higher likelihood of no PERR, highlighting the potential of the NLRP3 inflammasome as a predictor of worse clinical outcomes.
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 43
Open AccessNLRP3 Inflammasome as Potential Predictor of Non-Responsiveness to Immunosuppressive Treatment in Lupus Nephritis
Lupus nephritis (LN) can affect up to 60% of patients with systemic lupus erythematosus (SLE). The NLRP3 inflammasome has been implicated in the pathogenesis of LN. This study aimed to evaluate the role of the NLRP3 inflammasome as a predictor of response to immunosuppressive treatment in patients with active LN. A prospective cohort study was conducted with 20 adult patients with active LN, classes III, IV, and V, from January 2021 to September 2023. Patients were followed up at biopsy (T0) and 6 months (T6) and 12 months (T12) after treatment and classified according to the primary efficacy renal response (PERR) at 12 months. Gene expression of NLRP3, CARD8, CASP1, IL1B, and IL18 was evaluated by RT-qPCR in PBMCs. Immunohistochemistry (IHC) for NLRP3 was performed on kidney tissue. The concentration of cytokine IL-1β was measured using the BD™ Cytometric Bead Array (CBA). The mean age was 31.9 ± 8.3 years, with 19 females and 1 male. After 12 months, 65% of patients achieved PERR. The IHC intensity in inflammatory cells was higher in patients with no PERR (p = 0.0426). In the no-PERR group, the gene expression of IL1B showed a significant increase at T6 (FC = 2.22: p = 0.0037) and T12 (FC = 2.91; p = 0.0001) compared with T0. Relative expression of IL1B was higher in no-PERR patients at T12 compared to the PERR group (p = 0.0477). The no-PERR group also had higher serum IL-1β levels compared to the PERR group at 12 months (2.9 ± 0.5 vs. 2.5 ± 0.7, p = 0.0164). In conclusion, our study evidenced an increase in IL1B expression and IL-1β levels over the 12 months of treatment in no-PERR patients, suggesting a potential biomarker of disease activity. Furthermore, a strong NLRP3 IHC staining score was associated with a higher likelihood of no PERR, highlighting the potential of the NLRP3 inflammasome as a predictor of worse clinical outcomes.
- Open Access
- 14 August 2025
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 16, 1626477
Three weeks of environmental enrichment enhance hepatic-muscular oxidative balance and decrease interleukin-6 levels in juvenile female C57BL/6 mice
Introduction: The Environmental Enrichment (EE) promotes systemic responses through social, cognitive, sensory, and physical stimuli. However, its effects on hepatic and muscle oxidative balance, as well as on serum inflammation markers, remain unclear. Therefore, this study aimed to evaluate whether three weeks of EE could modulate hepatic and muscular oxidative balance and the inflammatory response in female C57BL/6 mice.Methods: The animals were divided into two groups: EE (n = 13) and Standard Environmental (SE, n = 11) from postnatal day 35 to 60. The EE setting included inanimate objects such as tunnels, ladders, and toys made of both wood and plastic. After three weeks, the mice were euthanized for the withdrawal of the liver, extensor digitorum longus (EDL), soleus, and blood samples.Results and discussion: EE significantly reduced body weight and malondialdehyde levels in the liver, soleus, and EDL muscles. Additionally, carbonyl levels decreased in the liver and soleus. Acute EE exposure enhanced enzymatic antioxidant activity (SOD, CAT, and GST) across all tissues, except for catalase activity in the EDL, which showed no significant difference between groups. Non-enzymatic defenses were improved, with reduced oxidized glutathione (GSSG) levels in the liver and soleus. Furthermore, EE increased the REDOX status in the liver and EDL. Sulfhydryl levels increased only in the liver. Finally, serum cytokine analysis revealed a significant reduction only in IL-6 levels. These findings suggest that three weeks of EE can modulate hepatic and muscular oxidative balance, as well as serum IL-6 levels, in juvenile female mice.
- 14 August 2025
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 16, 1626477
Open AccessThree weeks of environmental enrichment enhance hepatic-muscular oxidative balance and decrease interleukin-6 levels in juvenile female C57BL/6 mice
Introduction: The Environmental Enrichment (EE) promotes systemic responses through social, cognitive, sensory, and physical stimuli. However, its effects on hepatic and muscle oxidative balance, as well as on serum inflammation markers, remain unclear. Therefore, this study aimed to evaluate whether three weeks of EE could modulate hepatic and muscular oxidative balance and the inflammatory response in female C57BL/6 mice.Methods: The animals were divided into two groups: EE (n = 13) and Standard Environmental (SE, n = 11) from postnatal day 35 to 60. The EE setting included inanimate objects such as tunnels, ladders, and toys made of both wood and plastic. After three weeks, the mice were euthanized for the withdrawal of the liver, extensor digitorum longus (EDL), soleus, and blood samples.Results and discussion: EE significantly reduced body weight and malondialdehyde levels in the liver, soleus, and EDL muscles. Additionally, carbonyl levels decreased in the liver and soleus. Acute EE exposure enhanced enzymatic antioxidant activity (SOD, CAT, and GST) across all tissues, except for catalase activity in the EDL, which showed no significant difference between groups. Non-enzymatic defenses were improved, with reduced oxidized glutathione (GSSG) levels in the liver and soleus. Furthermore, EE increased the REDOX status in the liver and EDL. Sulfhydryl levels increased only in the liver. Finally, serum cytokine analysis revealed a significant reduction only in IL-6 levels. These findings suggest that three weeks of EE can modulate hepatic and muscular oxidative balance, as well as serum IL-6 levels, in juvenile female mice.
- 22 July 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e03261
Antibacterial Activity of ZnBTC‐MOF Combined With Essential Oil From Etlingera elatior and Major Compounds Against Staphylococcus aureus and Escherichia coli
In this work, an antibacterial material was designed with the incorporation of the essential oil (EO) from Etlingera elatior (Jack) R.M. Smith and its major compounds into a zinc metal–organic framework (MOF), ZnBTC, which was electrochemically synthesized and characterized by x‐ray diffraction (XRD), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and scanning electron microscopy (SEM). The composition of the EO was analyzed by gas chromatography (GC) and GC–mass spectrometry (GC–MS). The incorporation of the EO and its major compounds into ZnBTC‐MOF was verified through Brunauer–Emmett–Teller (BET) analysis. The microplate microdilution method was used to assess antibacterial activity. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined for all arrangements. Flow cytometry and SEM were carried out to analyze the mechanism of action of the compounds against bacterial cells. The results obtained with the combinations of ZnBTC‐MOF and the EO from E. elatior and its major compounds revealed a synergistic antibacterial effect on Escherichia coli and Staphylococcus aureus, with the enhancement of the individual antibacterial activities of these substances.
- 22 July 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e03261
Antibacterial Activity of ZnBTC‐MOF Combined With Essential Oil From Etlingera elatior and Major Compounds Against Staphylococcus aureus and Escherichia coli
In this work, an antibacterial material was designed with the incorporation of the essential oil (EO) from Etlingera elatior (Jack) R.M. Smith and its major compounds into a zinc metal–organic framework (MOF), ZnBTC, which was electrochemically synthesized and characterized by x‐ray diffraction (XRD), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and scanning electron microscopy (SEM). The composition of the EO was analyzed by gas chromatography (GC) and GC–mass spectrometry (GC–MS). The incorporation of the EO and its major compounds into ZnBTC‐MOF was verified through Brunauer–Emmett–Teller (BET) analysis. The microplate microdilution method was used to assess antibacterial activity. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined for all arrangements. Flow cytometry and SEM were carried out to analyze the mechanism of action of the compounds against bacterial cells. The results obtained with the combinations of ZnBTC‐MOF and the EO from E. elatior and its major compounds revealed a synergistic antibacterial effect on Escherichia coli and Staphylococcus aureus, with the enhancement of the individual antibacterial activities of these substances.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e288996
Allergic airway inflammation of offspring mice is suppressed by breast milk from Schistosoma mansoni-infected mothers
Maternal helminth infections could interfere with the establishment of postnatal immunity. Here, we evaluated the influence of maternal schistosomiasis during pregnancy or breastfeeding on the severity of allergic airway inflammation in adult offspring mice. Newborn mice were divided into four groups: animals Born from Infected Mothers (BIM) suckled by non-infected mothers; animals from non-infected mothers Suckled by Infected Mothers (SIM); and mice Born/Suckled by Infected Mothers (BSIM) or non-infected (Control). Six-week-old ovalbumin (OVA)-immunized mice on days 0 and 7 were exposed to aerosolized OVA at days 14 to 16. We analyzed the lung histology, leukocyte influx, and cytokine/eotaxin production in the bronchoalveolar lavage fluid (BALF) and spleen cell culture. Anti-OVA IgG1 and IgG2a isotype plasma levels were measured. In comparison to the Control group, there was a decreased influx of leukocytes, mainly eosinophils, in BALF, along with high IL-10 production and low IL-13 and eotaxin levels in animals SIM and BSIM). In SIM animals, a lower inflammatory response was also observed in the lung tissue, with macrophages present only in reactive areas. By contrast, in BIM animals, a rich infiltration of macrophages was observed in both lung histology and BALF, with lung production of IL-4 and splenic production of IL-13. No regulation in the antibody levels was observed. These findings suggest that previous contact with milk from S. mansoni-infected mothers may provide long-term protection against the development of allergic airway inflammation, while also highlighting the possible influence of early immunomodulation in individuals from endemic areas.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e288996
Open AccessAllergic airway inflammation of offspring mice is suppressed by breast milk from Schistosoma mansoni-infected mothers
Maternal helminth infections could interfere with the establishment of postnatal immunity. Here, we evaluated the influence of maternal schistosomiasis during pregnancy or breastfeeding on the severity of allergic airway inflammation in adult offspring mice. Newborn mice were divided into four groups: animals Born from Infected Mothers (BIM) suckled by non-infected mothers; animals from non-infected mothers Suckled by Infected Mothers (SIM); and mice Born/Suckled by Infected Mothers (BSIM) or non-infected (Control). Six-week-old ovalbumin (OVA)-immunized mice on days 0 and 7 were exposed to aerosolized OVA at days 14 to 16. We analyzed the lung histology, leukocyte influx, and cytokine/eotaxin production in the bronchoalveolar lavage fluid (BALF) and spleen cell culture. Anti-OVA IgG1 and IgG2a isotype plasma levels were measured. In comparison to the Control group, there was a decreased influx of leukocytes, mainly eosinophils, in BALF, along with high IL-10 production and low IL-13 and eotaxin levels in animals SIM and BSIM). In SIM animals, a lower inflammatory response was also observed in the lung tissue, with macrophages present only in reactive areas. By contrast, in BIM animals, a rich infiltration of macrophages was observed in both lung histology and BALF, with lung production of IL-4 and splenic production of IL-13. No regulation in the antibody levels was observed. These findings suggest that previous contact with milk from S. mansoni-infected mothers may provide long-term protection against the development of allergic airway inflammation, while also highlighting the possible influence of early immunomodulation in individuals from endemic areas.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 58, e13915
Prevalence of invasive yeast infections in a COVID-19 intensive care unit in northeastern Brazil
The COVID-19 pandemic has caused a global crisis, overwhelming hospitals and intensive care units (ICU) and leading to an increase in nosocomial infections due to prolonged hospitalization and other risk factors. The present study evaluated the prevalence of secondary fungal infections in critically ill patients with COVID-19. This is a retrospective, single-center study conducted in a hospital in northeastern Brazil, which evaluated 1,364 medical records of patients admitted to a COVID-19 ICU during 2020 and 2021. A total of 327 pathogenic yeasts were isolated from 132 (40.4%) respiratory, 70 (21.4%) blood, 124 (37.9%) urine, and one (0.3%) surgical wound samples. Fungal infections were diagnosed in the intermediate (5 to 12 days) or late (≥12 days) stage of hospitalization. The most frequent yeast isolated from critically ill COVID-19 patients was Candida albicans [126 (67.7%) and 60 (42.6%)], followed by Candida tropicalis [25 (13.4%) and 39 (27.7%)]. Candida parapsilosis isolates increased 5.7-fold in 2021 [40 (28.4%)] compared to 2020 [7 (3.8%)]. The least frequently isolated in 2020 and 2021 were Nakaseomyces glabratus [4 (2.2%) and 1 (0.7%)], and Pichia kudriavzevii, which was isolated only in 2021 (1 (0.7%)). During the study period, a decrease in susceptibility to antifungals was observed: susceptibility to voriconazole reduced from 100 to 77.2%, to flucytosine from 99.4 to 78.8%, and to micafungin from 99.4 to 83.6%. The changes in the frequency of species causing secondary infections in critically ill COVID-19 patients and susceptibility to the antifungals indicate the need for early and adequate diagnosis to minimize negative outcomes.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 58, e13915
Open AccessPrevalence of invasive yeast infections in a COVID-19 intensive care unit in northeastern Brazil
The COVID-19 pandemic has caused a global crisis, overwhelming hospitals and intensive care units (ICU) and leading to an increase in nosocomial infections due to prolonged hospitalization and other risk factors. The present study evaluated the prevalence of secondary fungal infections in critically ill patients with COVID-19. This is a retrospective, single-center study conducted in a hospital in northeastern Brazil, which evaluated 1,364 medical records of patients admitted to a COVID-19 ICU during 2020 and 2021. A total of 327 pathogenic yeasts were isolated from 132 (40.4%) respiratory, 70 (21.4%) blood, 124 (37.9%) urine, and one (0.3%) surgical wound samples. Fungal infections were diagnosed in the intermediate (5 to 12 days) or late (≥12 days) stage of hospitalization. The most frequent yeast isolated from critically ill COVID-19 patients was Candida albicans [126 (67.7%) and 60 (42.6%)], followed by Candida tropicalis [25 (13.4%) and 39 (27.7%)]. Candida parapsilosis isolates increased 5.7-fold in 2021 [40 (28.4%)] compared to 2020 [7 (3.8%)]. The least frequently isolated in 2020 and 2021 were Nakaseomyces glabratus [4 (2.2%) and 1 (0.7%)], and Pichia kudriavzevii, which was isolated only in 2021 (1 (0.7%)). During the study period, a decrease in susceptibility to antifungals was observed: susceptibility to voriconazole reduced from 100 to 77.2%, to flucytosine from 99.4 to 78.8%, and to micafungin from 99.4 to 83.6%. The changes in the frequency of species causing secondary infections in critically ill COVID-19 patients and susceptibility to the antifungals indicate the need for early and adequate diagnosis to minimize negative outcomes.
- Open Access
- 30 August 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1416715
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
Objectives: This study was performed to identify predictive markers of worse outcomes in patients with severe COVID-19 in an intensive care unit.Methods: Sixty patients with severe COVID-19, hospitalized in the Intensive Care Unit (ICU) between March and July 2021, were stratified into two groups according to the outcome survivors and non-survivors. After admission to the ICU, blood samples were collected directly for biomarker analysis. Routine hematological and biochemical biomarkers, as well as serum levels of cytokines, chemokines, and immunoglobulins, were investigated.Results: Lymphopenia, neutrophilia, and thrombocytopenia were more pronounced in non-surviving patients, while the levels of CRP, AST, creatinine, ferritin, AST, troponin I, urea, magnesium, and potassium were higher in the non-surviving group than the survival group. In addition, serum levels of IL-10, CCL2, CXCL9, and CXCL10 were significantly increased in patients who did not survive. These changes in the biomarkers evaluated were associated with increased mortality in patients with severe COVID-19.Conclusion: The present study confirmed and expanded the validity of laboratory biomarkers as indicators of mortality in severe COVID-19.
- 30 August 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1416715
Open AccessPredictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
Objectives: This study was performed to identify predictive markers of worse outcomes in patients with severe COVID-19 in an intensive care unit.Methods: Sixty patients with severe COVID-19, hospitalized in the Intensive Care Unit (ICU) between March and July 2021, were stratified into two groups according to the outcome survivors and non-survivors. After admission to the ICU, blood samples were collected directly for biomarker analysis. Routine hematological and biochemical biomarkers, as well as serum levels of cytokines, chemokines, and immunoglobulins, were investigated.Results: Lymphopenia, neutrophilia, and thrombocytopenia were more pronounced in non-surviving patients, while the levels of CRP, AST, creatinine, ferritin, AST, troponin I, urea, magnesium, and potassium were higher in the non-surviving group than the survival group. In addition, serum levels of IL-10, CCL2, CXCL9, and CXCL10 were significantly increased in patients who did not survive. These changes in the biomarkers evaluated were associated with increased mortality in patients with severe COVID-19.Conclusion: The present study confirmed and expanded the validity of laboratory biomarkers as indicators of mortality in severe COVID-19.
- Open Access
HIV-Induced Thymic Insufficiency and Aging-Related Immunosenescence on Immune Reconstitution in ART-Treated Patients
The mechanisms underlying unsatisfactory immune reconstitution in HIV-1 positive patients under ART have not been fully elucidated, even after years of investigation. Thus, this study aimed to assess the correlation between age and thymic production profile, and its influence on inadequate immunological recovery. Here, 44 ART-treated patients with undetectable plasma HIV-1 load (p = 0.041). Evaluating RTE CD4+ T-cells, we observed a lower percentage in the INR group (19.5 ± 6.3) compared to the IR group (29.9 ± 11.5) (p = 0.012). There was a strong negative correlation between age at ART initiation and RTE CD4+ T-cells in INRs (r = −0.784, p = 0.004). Our study has highlighted the thymic insufficiency and aging-related immunosenescence with unsatisfactory immunological recovery during ART in HIV-1 positive patients.
Open AccessHIV-Induced Thymic Insufficiency and Aging-Related Immunosenescence on Immune Reconstitution in ART-Treated Patients
The mechanisms underlying unsatisfactory immune reconstitution in HIV-1 positive patients under ART have not been fully elucidated, even after years of investigation. Thus, this study aimed to assess the correlation between age and thymic production profile, and its influence on inadequate immunological recovery. Here, 44 ART-treated patients with undetectable plasma HIV-1 load (p = 0.041). Evaluating RTE CD4+ T-cells, we observed a lower percentage in the INR group (19.5 ± 6.3) compared to the IR group (29.9 ± 11.5) (p = 0.012). There was a strong negative correlation between age at ART initiation and RTE CD4+ T-cells in INRs (r = −0.784, p = 0.004). Our study has highlighted the thymic insufficiency and aging-related immunosenescence with unsatisfactory immunological recovery during ART in HIV-1 positive patients.